Answer
Breastfeeding is not recommended during asciminib hydrochloride treatment and for at least 3 days after stopping because of potential serious adverse reactions in the breastfed newborn or infant.
Sources for this answer
- Scemblix 20 mg and 40 mg film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked